Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

606 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neutralization of SARS-CoV-2 requires antibodies against conformational receptor-binding domain epitopes.
Gattinger P, Niespodziana K, Stiasny K, Sahanic S, Tulaeva I, Borochova K, Dorofeeva Y, Schlederer T, Sonnweber T, Hofer G, Kiss R, Kratzer B, Trapin D, Tauber PA, Rottal A, Körmöczi U, Feichter M, Weber M, Focke-Tejkl M, Löffler-Ragg J, Mühl B, Kropfmüller A, Keller W, Stolz F, Henning R, Tancevski I, Puchhammer-Stöckl E, Pickl WF, Valenta R. Gattinger P, et al. Among authors: henning r. Allergy. 2022 Jan;77(1):230-242. doi: 10.1111/all.15066. Epub 2021 Sep 22. Allergy. 2022. PMID: 34453317 Free PMC article.
Antibodies in serum of convalescent patients following mild COVID-19 do not always prevent virus-receptor binding.
Gattinger P, Borochova K, Dorofeeva Y, Henning R, Kiss R, Kratzer B, Mühl B, Perkmann T, Trapin D, Trella M, Ettel P, Tulaeva I, Pickl WF, Valenta R. Gattinger P, et al. Among authors: henning r. Allergy. 2021 Mar;76(3):878-883. doi: 10.1111/all.14523. Epub 2020 Aug 27. Allergy. 2021. PMID: 32734595 Free PMC article. No abstract available.
Immunological imprint of COVID-19 on human peripheral blood leukocyte populations.
Kratzer B, Trapin D, Ettel P, Körmöczi U, Rottal A, Tuppy F, Feichter M, Gattinger P, Borochova K, Dorofeeva Y, Tulaeva I, Weber M, Grabmeier-Pfistershammer K, Tauber PA, Gerdov M, Mühl B, Perkmann T, Fae I, Wenda S, Führer H, Henning R, Valenta R, Pickl WF. Kratzer B, et al. Among authors: henning r. Allergy. 2021 Mar;76(3):751-765. doi: 10.1111/all.14647. Epub 2020 Nov 22. Allergy. 2021. PMID: 33128792 Free PMC article.
Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy.
Focke-Tejkl M, Weber M, Niespodziana K, Neubauer A, Huber H, Henning R, Stegfellner G, Maderegger B, Hauer M, Stolz F, Niederberger V, Marth K, Eckl-Dorna J, Weiss R, Thalhamer J, Blatt K, Valent P, Valenta R. Focke-Tejkl M, et al. Among authors: henning r. J Allergy Clin Immunol. 2015 May;135(5):1207-7.e1-11. doi: 10.1016/j.jaci.2014.09.012. Epub 2014 Nov 13. J Allergy Clin Immunol. 2015. PMID: 25441634 Free PMC article.
Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope-based grass pollen allergy vaccine with allergen extract-based vaccines.
Weber M, Niespodziana K, Linhart B, Neubauer A, Huber H, Henning R, Valenta R, Focke-Tejkl M. Weber M, et al. Among authors: henning r. J Allergy Clin Immunol. 2017 Nov;140(5):1433-1436.e6. doi: 10.1016/j.jaci.2017.03.048. Epub 2017 May 31. J Allergy Clin Immunol. 2017. PMID: 28576673 Free PMC article. No abstract available.
Skin test evaluation of a novel peptide carrier-based vaccine, BM32, in grass pollen-allergic patients.
Niederberger V, Marth K, Eckl-Dorna J, Focke-Tejkl M, Weber M, Hemmer W, Berger U, Neubauer A, Stolz F, Henning R, Valenta R. Niederberger V, et al. Among authors: henning r. J Allergy Clin Immunol. 2015 Oct;136(4):1101-3.e8. doi: 10.1016/j.jaci.2015.03.034. Epub 2015 Jun 3. J Allergy Clin Immunol. 2015. PMID: 26048664 Free PMC article. Clinical Trial. No abstract available.
Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32.
Niederberger V, Neubauer A, Gevaert P, Zidarn M, Worm M, Aberer W, Malling HJ, Pfaar O, Klimek L, Pfützner W, Ring J, Darsow U, Novak N, Gerth van Wijk R, Eckl-Dorna J, Focke-Tejkl M, Weber M, Müller HH, Klinger J, Stolz F, Breit N, Henning R, Valenta R. Niederberger V, et al. Among authors: henning r. J Allergy Clin Immunol. 2018 Aug;142(2):497-509.e9. doi: 10.1016/j.jaci.2017.09.052. Epub 2018 Jan 17. J Allergy Clin Immunol. 2018. PMID: 29361332 Free PMC article. Clinical Trial.
Quantification, epitope mapping and genotype cross-reactivity of hepatitis B preS-specific antibodies in subjects vaccinated with different dosage regimens of BM32.
Tulaeva I, Cornelius C, Zieglmayer P, Zieglmayer R, Schmutz R, Lemell P, Weber M, Focke-Tejkl M, Karaulov A, Henning R, Valenta R. Tulaeva I, et al. Among authors: henning r. EBioMedicine. 2020 Sep;59:102953. doi: 10.1016/j.ebiom.2020.102953. Epub 2020 Aug 24. EBioMedicine. 2020. PMID: 32855110 Free PMC article.
606 results